✦ LIBER ✦

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

✍ Scribed by Lötvall, Jan; Bleecker, Eugene R.; Busse, William W.; O'Byrne, Paul M.; Woodcock, Ashley; Kerwin, Edward M.; Stone, Sally; Forth, Richard; Jacques, Loretta; Bateman, Eric D.

Book ID: 121722638
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 621 KB
Volume: 108
Category: Article
ISSN: 0954-6111
DOI: 10.1016/j.rmed.2013.11.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of once-daily flutic

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial

✍ Paul M O’Byrne,Ashley Woodcock,Eugene R Bleecker,Eric D Bateman… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 711 KB

Efficacy and safety of fluticasone propi

Efficacy and safety of fluticasone propionate 250 μg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids

✍ Berger, William E.; Ford, Linda B.; Mahr, Todd; Nathan, Robert A.; Crim, Courtne 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 284 KB

A10/291 – Efficacy and safety of cicleso

A10/291 – Efficacy and safety of ciclesonide 320 μg once daily compared with budesonide 800 μg once daily in adolescent patients with severe persistent asthma

✍ J.H. Vermeulen; T. Latos; U. Freudensprung; C. Stader; H. Rauer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Safety, tolerability and efficacy of ind

Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

✍ Jutta Beier; Pascal Chanez; Jean-Benoit Martinot; A.J.M. Schreurs; Ružena Tkáčov 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Efficacy and safety of belimumab in pati

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

✍ Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Le 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 239 KB

Efficacy and safety of linagliptin 2.5 m

Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial

✍ Ross, Stuart A.; Rafeiro, Elizabeth; Meinicke, Thomas; Toorawa, Robert; Weber-Bo 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 254 KB